Search for: "Alliance v. Lilly"
Results 21 - 32
of 32
Sort by Relevance
|
Sort by Date
27 Oct 2010, 3:38 am
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows… [read post]
15 Jul 2010, 2:39 pm
Universal Crop Protection Alliance, 2007 WL 2811533 (E.D. [read post]
12 Dec 2008, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Intergovernmental Meeting on Pandemic Influenza Preparedness, Geneva: tension over IP issues related to virus and vaccine sharing (Intellectual Property Watch) (Intellectual Property Watch) Actos (Pioglitazone) – US: CAFC affirms attorney fee of over $16 million in connection with ANDA patent challenge: Takeda v… [read post]
9 Aug 2008, 1:50 am
: (Patenting Lives), Worldwide increase in patent filings puts strain on system: (Managing Intellectual Property), WIPO releases 2008 Worldwide Patent Report: (Peter Zura's 271 Patent Blog), (Patent Prospector), (IP Updates), Global patent filings continue rise but may level off; smaller nationals slipping: (Intellectual Property Watch), Means plus function: Don’t ignore the man behind the curtain: (Intellectual Property Directions), Technology start-up entrepreneurs and CEOs: If your… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
7 Mar 2008, 2:00 am
: (IPEG), Property Rights Alliance releases ‘International property rights index 2008 report’ ranking countries on the level of protection they provide to IP: (IAM), (Spicy IP), (Afro-IP), Analysis of Microsoft’s open arms: (Innovationpartners) Intellectual Property Watch discussion forum: Should the International Standards Organisation approve the Microsoft OOXML document format as a global standard? [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The … [read post]
18 Dec 2007, 7:42 am
Peter Hospital 413 Lilly Road N.E. [read post]
15 Feb 2007, 1:02 pm
A US District Court judge today refused Eli Lilly's request to ban a number of websites from publishing leaked documents relating to Zyprexa, Eli Lilly's top-selling drug. [read post]
21 Jan 2007, 5:42 pm
We have not seen, in any of the Court’s recent opinions, discussion of patents as “monopolies,” along the lines of Justice Douglas’ concurrence in Great Atlantic & Pacific Tea Co. v. [read post]
